These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 188277)

  • 1. [Study of leukotoxic activity of Cl. perfringens type A toxin and its fractions obtained by gel filtration and ion exchange chromatography].
    Tselukh AV; Protchenko PZ; Golovatiuk AL
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Jul; (7):119-23. PubMed ID: 188277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of the leukotoxic action of Clostridium perfringens type A toxin on the phagocytic activity of blood neutrophils taking into consideration the leukocytic reaction].
    Golovatiuk AL
    Mikrobiol Zh; 1973; 35(5):596-600. PubMed ID: 4361316
    [No Abstract]   [Full Text] [Related]  

  • 3. Clostridium perfringens type D epsilon prototoxin. Some chemical, immunological and biological properties of a highly purified prototoxin.
    Worthington RW; Mülders MS; Van Rensburg JJ
    Onderstepoort J Vet Res; 1973 Dec; 40(4):143-9. PubMed ID: 4369870
    [No Abstract]   [Full Text] [Related]  

  • 4. Conformational studies on modified proteins and peptides. VII. Conformation of epsilon-prototoxin and epsilon-toxin from Clostridium perfringens. Conformational changes associated with toxicity.
    Habeeb AF; Lee CL; Atassi MZ
    Biochim Biophys Acta; 1973 Oct; 322(2):245-50. PubMed ID: 4358084
    [No Abstract]   [Full Text] [Related]  

  • 5. [Isolation of the theta-hemolysin of Cl. perfringens].
    Dolgikh MS; Blagoveshchenskiĭ VA; Sergeeva TI; Novoselova GN
    Vopr Med Khim; 1981; 27(1):129-32. PubMed ID: 6258318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium perfringens exotoxins. I. Purification and properties of -toxin.
    Mitsu K; Mitsui N; Hase J
    Jpn J Exp Med; 1973 Apr; 43(2):65-80. PubMed ID: 4352113
    [No Abstract]   [Full Text] [Related]  

  • 7. Clostridium perfringens exotoxins. II. Purification and some properties of theta-toxin.
    Mitsui K; Mitsui N; Hase J
    Jpn J Exp Med; 1973 Oct; 43(5):377-91. PubMed ID: 4359556
    [No Abstract]   [Full Text] [Related]  

  • 8. [Observations on the leukotoxic, hemolytic and lecithinase activity of toxins of Cl. perfringens of different age].
    SYTNIK Ia
    Zh Mikrobiol Epidemiol Immunobiol; 1960 Feb; 31():100-8. PubMed ID: 13836244
    [No Abstract]   [Full Text] [Related]  

  • 9. [The role of Cl. perfringens lecithinase in the effect of the toxin on tissue cultures].
    Shamraeva SA; Shemanova GF; Vlasova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Oct; 43(10):20-4. PubMed ID: 4305232
    [No Abstract]   [Full Text] [Related]  

  • 10. Alpha toxoid of Clostridium perfringens. I. Purification and toxoiding of alpha toxin of C. perfringens.
    Ito A
    Jpn J Med Sci Biol; 1968 Dec; 21(6):379-91. PubMed ID: 4306752
    [No Abstract]   [Full Text] [Related]  

  • 11. Two molecular forms of Clostridium perfringens alpha-toxin associated with lethal, hemolytic and enzymatic activities.
    Sugahara T; Osaka A
    Jpn J Med Sci Biol; 1970 Feb; 23(1):61-6. PubMed ID: 4317541
    [No Abstract]   [Full Text] [Related]  

  • 12. [Purification and some properties of "Clostridium perfringens" delta toxin (author's transl)].
    Tixier G; Alouf JE
    Ann Microbiol (Paris); 1976; 127B(4):509-24. PubMed ID: 192118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of phospholipase C (alpha-toxin) from Clostridium perfringens.
    Möllby R; Wadström T
    Biochim Biophys Acta; 1973 Oct; 321(2):569-84. PubMed ID: 4357667
    [No Abstract]   [Full Text] [Related]  

  • 14. [Extraction of dry concentrated toxin from Cl. perfringens type E].
    Zemlianitskaia EP; Samsonova VS
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Jun; 43(6):94-8. PubMed ID: 4308596
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship of route of inoculation and nature of toxin preparation to bioassay of Clostridium perfringens alpha-toxin in mice.
    Lynch KL; Moskowitz M
    J Bacteriol; 1968 Dec; 96(6):1920-4. PubMed ID: 4302137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homology between enterotoxin protein and spore structural protein in Clostridium perfringens type A.
    Frieben WR; Duncan CL
    Eur J Biochem; 1973 Nov; 39(2):393-401. PubMed ID: 4359628
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of lecithinase C of Cl. perfringens type A on blood, bone marrow and phagocytic activity of the leukocytes of guinea pigs immunized with analecithinase].
    Anosov IIa; Larina IA; Ispolatovskaia MV
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Oct; 48(10):65-9. PubMed ID: 4330845
    [No Abstract]   [Full Text] [Related]  

  • 18. [Production, purification and characterization of some Clostridium perfringens toxins].
    Capunzo M; Mariano A; Cavallo R
    G Batteriol Virol Immunol; 1982; 75(1-6):48-61. PubMed ID: 6315516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in the electrical activity of the cerebral cortex under the combined influence of Cl. perfringens type A toxin and products of Cl. butyricum activity].
    Tselukh AV; Makul'kon RF; Kryzhanovskiĭ GN
    Biull Eksp Biol Med; 1976; 82(11):1305-10. PubMed ID: 189855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of perfringens toxin on phagocytosis and leukocyte viability].
    Mihancea N; Bittner J; Toacsen E; Ceacăreanu A; Teodorescu G
    Arch Roum Pathol Exp Microbiol; 1970; 29(1):159-67. PubMed ID: 4328002
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.